294 related articles for article (PubMed ID: 14730005)
1. In vivo activity of a phospholipase C inhibitor, 1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), in acute and chronic inflammatory reactions.
Hou C; Kirchner T; Singer M; Matheis M; Argentieri D; Cavender D
J Pharmacol Exp Ther; 2004 May; 309(2):697-704. PubMed ID: 14730005
[TBL] [Abstract][Full Text] [Related]
2. The phosphoinositide-specific phospholipase C inhibitor U73122 (1-(6-((17beta-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) spontaneously forms conjugates with common components of cell culture medium.
Wilsher NE; Court WJ; Ruddle R; Newbatt YM; Aherne W; Sheldrake PW; Jones NP; Katan M; Eccles SA; Raynaud FI
Drug Metab Dispos; 2007 Jul; 35(7):1017-22. PubMed ID: 17403917
[TBL] [Abstract][Full Text] [Related]
3. 1-[6-[[(17beta)-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122) selectively inhibits Kir3 and BK channels in a phospholipase C-independent fashion.
Klose A; Huth T; Alzheimer C
Mol Pharmacol; 2008 Nov; 74(5):1203-14. PubMed ID: 18682550
[TBL] [Abstract][Full Text] [Related]
4. The aminosteroid phospholipase C antagonist U-73122 (1-[6-[[17-beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) potently inhibits human 5-lipoxygenase in vivo and in vitro.
Feisst C; Albert D; Steinhilber D; Werz O
Mol Pharmacol; 2005 May; 67(5):1751-7. PubMed ID: 15684042
[TBL] [Abstract][Full Text] [Related]
5. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.
Smith RJ; Sam LM; Justen JM; Bundy GL; Bala GA; Bleasdale JE
J Pharmacol Exp Ther; 1990 May; 253(2):688-97. PubMed ID: 2338654
[TBL] [Abstract][Full Text] [Related]
6. U73122, an aminosteroid phospholipase C inhibitor, is a potent inhibitor of cardiac phospholipase D by a PIP2-dependent mechanism.
Burgdorf C; Schäfer U; Richardt G; Kurz T
J Cardiovasc Pharmacol; 2010 Jun; 55(6):555-9. PubMed ID: 20179606
[TBL] [Abstract][Full Text] [Related]
7. Role of cyclooxygenase-1 and -2, phospholipase C, and protein kinase C in prostaglandin-mediated gastroprotection.
Peskar BM; Sawka N; Ehrlich K; Peskar BA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1233-8. PubMed ID: 12626649
[TBL] [Abstract][Full Text] [Related]
8. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin- and thrombin-induced increases in endothelial permeability occur independently of phospholipase C but require protein kinase C activation.
Aschner JL; Lum H; Fletcher PW; Malik AB
J Cell Physiol; 1997 Dec; 173(3):387-96. PubMed ID: 9369952
[TBL] [Abstract][Full Text] [Related]
10. The involvement of phospholipase C in crystal induced human neutrophil activation.
Jackon JK; Tudan C; Burt HM
J Rheumatol; 2000 Dec; 27(12):2877-85. PubMed ID: 11128680
[TBL] [Abstract][Full Text] [Related]
11. The effects of bradykinin on K+ currents in NG108-15 cells treated with U73122, a phospholipase C inhibitor, or neomycin.
Hildebrandt JP; Plant TD; Meves H
Br J Pharmacol; 1997 Mar; 120(5):841-50. PubMed ID: 9138690
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and molecular characterization of the mechanisms involved in prostaglandin E2-induced mouse paw edema.
Claudino RF; Kassuya CA; Ferreira J; Calixto JB
J Pharmacol Exp Ther; 2006 Aug; 318(2):611-8. PubMed ID: 16644903
[TBL] [Abstract][Full Text] [Related]
13. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
Vickers JD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627
[TBL] [Abstract][Full Text] [Related]
14. Norepinephrine-induced changes in gene expression of phospholipase C in cardiomyocytes.
Singal T; Dhalla NS; Tappia PS
J Mol Cell Cardiol; 2006 Jul; 41(1):126-37. PubMed ID: 16714034
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ signalling mechanisms of the beta 2 integrin on neutrophils: involvement of phospholipase C gamma 2 and Ins(1,4,5)P3.
Hellberg C; Molony L; Zheng L; Andersson T
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):403-9. PubMed ID: 8713065
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity.
Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ
Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361
[TBL] [Abstract][Full Text] [Related]
17. Role of phospholipase C-beta in the modulation of epithelial tight junction permeability.
Ward PD; Ouyang H; Thakker DR
J Pharmacol Exp Ther; 2003 Feb; 304(2):689-98. PubMed ID: 12538823
[TBL] [Abstract][Full Text] [Related]
18. U73122 and U73343 inhibit receptor-mediated phospholipase D activation downstream of phospholipase C in CHO cells.
Bosch RR; Patel AM; Van Emst-de Vries SE; Smeets RL; De Pont JJ; Willems PH
Eur J Pharmacol; 1998 Apr; 346(2-3):345-51. PubMed ID: 9652379
[TBL] [Abstract][Full Text] [Related]
19. U-73122, an aminosteroid phospholipase C inhibitor, may also block Ca2+ influx through phospholipase C-independent mechanism in neutrophil activation.
Wang JP
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):599-605. PubMed ID: 8738291
[TBL] [Abstract][Full Text] [Related]
20. The phospholipase C inhibitor U73122 attenuates trans-10, cis-12 conjugated linoleic acid-mediated inflammatory signaling and insulin resistance in human adipocytes.
Shen W; Martinez K; Chuang CC; McIntosh M
J Nutr; 2013 May; 143(5):584-90. PubMed ID: 23468551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
